MIA
ABBV icon

Madison Investment Advisors’s AbbVie ABBV Stock Holding History

Madison Investment Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		$15M Buy
+84,227
New +$15.5M 0.17% 109

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Madison Investment Advisors's ABBV Position: Q4 2024 in Review

Madison Investment Advisors opened a new position in AbbVie (ABBV) in Q4 2024: 84,227 shares worth $15M. The stake represents 0.17% of the portfolio and ranks #109 among its holdings.

3,750 funds tracked by Wall St. Rank hold ABBV as of Q4 2024.

  • Madison Investment Advisors held 84,227 shares of AbbVie worth $15M as of Q4 2024.
  • AbbVie was a new Madison Investment Advisors position in Q4 2024.
  • AbbVie made up 0.17% of Madison Investment Advisors's portfolio in Q4 2024, its #109 holding.
  • 3,750 funds tracked by Wall St. Rank held AbbVie as of Q4 2024.

Based on Madison Investment Advisors's 13F filing for Q4 2024, filed 10 Feb 2025.